Roundtable Discussion; The Future of Mineral Sands. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksGlaxosmithkline Share News (GSK)

Share Price Information for Glaxosmithkline (GSK)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 1,733.50
Bid: 1,732.50
Ask: 1,733.00
Change: 5.00 (0.29%)
Spread: 0.50 (0.029%)
Open: 1,733.00
High: 1,739.50
Low: 1,724.50
Prev. Close: 1,728.50
GSK Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

London open: Fed taper sparks 'Santa Rally' as stocks jump

Thu, 19th Dec 2013 08:17

- Fed cuts monthly bond buying to 75bn dollars- Commits to near-zero rates, depending on inflation- Pharma peers AstraZeneca, GSK making gainstechMARK 2,727.60 +1.12%FTSE 100 6,553.38 +0.94%FTSE 250 15,550.52 +1.20%UK markets opened around one per cent higher on Thursday morning in the aftermath of the Federal Reserve's decision to taper its quantitative easing programme, as investors welcomed the end to months of uncertainty."This should in turn remove much of the volatility that we have seen in the final quarter of 2013, gearing us up for a delayed but eagerly anticipated 'Santa Rally' to finish this year in a bang and kick off the next year in an upbeat fashion," said Market Strategist Ishaq Siddiqi from ETX Capital.The Federal Reserve announced on Wednesday night that it would scale back its monthly bond-buying programme from $85bn to $75bn and said it would make similar moderate reductions in the future subject to incoming economic data. The news sent both the Dow Jones Industrial Average and S&P 500 to new record highs on Wall Street.Policymakers predicted that the jobless rate - currently at 7% - would drop to around 6.5% by the end of 2014. However, they stressed that they would hold interest rates close to zero "well past the time that the unemployment rate declines below 6.5%, especially if projected inflation continues to run below the [FOMC's] 2% longer-run goal"."The action today is intended to keep the level of accommodation the same overall and to push the economy forward," said Chairman Ben Bernanke. "We are committed to doing what is necessary to getting inflation back to target."AstraZeneca jumps on BMS dealAstraZeneca was a high riser this morning after spending up to $4.1bn in Bristol-Myers Squibb's stake in their diabetes joint venture, giving the British company full ownership of intellectual property and global rights for a large portfolio of products.Fellow pharma group GlaxoSmithKline (GSK) also advanced after announcing yesterday evening that US regulators have approved Anoro Ellipta, its treatment for chronic obstructive pulmonary disease. Upside however was limited on the news that Denmark has approved the sale of a generic copy of GSK's biggest product, Advair.There were just a handful of fallers on the FTSE 100 early on, with mining peers Fresnillo and Randgold Resources among them as precious metals prices declined. Support services group Serco fell after warning that recent contract problems may hit its cash flow this year. However, it still said 2013 results were likely to meet market hopes.Financial stocks were mixed with RSA Insurance, Standard Chartered and HSBC trading lower, and Barclays, Resolution and Prudential among the best performers.FTSE 100 - RisersPetrofac Ltd. (PFC) 1,122.00p +3.03%BAE Systems (BA.) 446.20p +2.79%Resolution Ltd. (RSL) 335.90p +2.50%Hammerson (HMSO) 502.50p +2.49%Standard Life (SL.) 348.60p +2.44%Persimmon (PSN) 1,196.00p +2.40%Land Securities Group (LAND) 949.50p +2.32%WPP (WPP) 1,328.00p +2.31%ITV (ITV) 185.40p +2.26%Prudential (PRU) 1,299.00p +2.20%FTSE 100 - FallersRandgold Resources Ltd. (RRS) 3,820.00p -2.45%Fresnillo (FRES) 717.00p -1.38%Standard Chartered (STAN) 1,309.00p -0.76%HSBC Holdings (HSBA) 643.40p -0.76%RSA Insurance Group (RSA) 89.90p -0.72%United Utilities Group (UU.) 647.50p -0.46%Severn Trent (SVT) 1,674.00p -0.24%Sainsbury (J) (SBRY) 364.80p -0.08%Glencore Xstrata (GLEN) 306.50p -0.08%FTSE 250 - RisersRedrow (RDW) 308.00p +3.39%Close Brothers Group (CBG) 1,374.00p +3.31%Bovis Homes Group (BVS) 783.00p +2.96%Jupiter Fund Management (JUP) 377.30p +2.95%Supergroup (SGP) 1,401.00p +2.86%Henderson Group (HGG) 208.40p +2.86%Keller Group (KLR) 1,135.00p +2.81%Halfords Group (HFD) 451.60p +2.80%Shaftesbury (SHB) 613.50p +2.76%SEGRO (SGRO) 333.60p +2.71%FTSE 250 - FallersAfrican Barrick Gold (ABG) 155.00p -3.73%Serco Group (SRP) 437.50p -2.52%Polymetal International (POLY) 511.00p -1.26%Hochschild Mining (HOC) 125.10p -1.11%888 Holdings (888) 159.50p -0.93%BH Macro Ltd. EUR Shares (BHME) € 19.81 -0.90%Diploma (DPLM) 704.50p -0.77%Barr (A.G.) (BAG) 568.00p -0.61%Cable & Wireless Communications (CWC) 52.30p -0.57%NMC Health (NMC) 442.50p -0.56%BC
More News
3 Jan 2024 17:48

London close: Stocks fall amid rising geopolitical concerns

(Sharecast News) - London stocks closed lower on Wednesday - the 40th anniversary of the FTSE 100's launch - as sentiment remained cautious due to increasing tensions in the Middle East.

Read more
3 Jan 2024 17:10

Miners, personal goods stocks drag FTSE 100 to two-week low

Burberry slips on rating downgrade

*

Read more
3 Jan 2024 16:52

LONDON MARKET CLOSE: Stocks down ahead of US Fed minutes

(Alliance News) - Stock prices in London closed lower on Wednesday, as investors nervously look ahead to the latest US Federal Reserve meeting minutes.

Read more
3 Jan 2024 12:10

LONDON MARKET MIDDAY: Stocks down before Fed minutes and US PMI data

(Alliance News) - Stock prices in London were down at midday on Wednesday, in cautious trade ahead of key US data and central bank minutes in the afternoon.

Read more
3 Jan 2024 11:07

Jefferies upgrades GSK to 'buy', cuts AstraZeneca to 'hold'

(Sharecast News) - Jefferies has upgraded its rating on GlaxoSmithKline to 'buy' and cut AstraZeneca to 'hold' as part of its review of the European pharma sector.

Read more
3 Jan 2024 09:23

LONDON BROKER RATINGS: GSK raised to 'buy'; AstraZeneca cut to 'hold'

(Alliance News) - The following London-listed shares received analyst recommendations Wednesday morning and Tuesday:

Read more
3 Jan 2024 08:58

LONDON MARKET OPEN: Stocks mixed pre-Fed minutes, amid Asia losses

(Alliance News) - Stock prices in London opened mixed on Wednesday, ahead of US Federal Reserve meeting minutes and manufacturing PMI data for the US in the evening and afternoon respectively.

Read more
3 Jan 2024 07:54

LONDON BRIEFING: Stocks to open flat pre-Fed minutes, jobs data

(Alliance News) - The FTSE 100 is expected to open flat on Wednesday, as London's flagship index celebrates its 40th anniversary, after mostly downbeat trading in Asia and a tech sell-off in New York.

Read more
29 Dec 2023 13:01

LONDON MARKET CLOSE: UK equities outclassed by other markets in 2023

(Alliance News) - Stock prices in London closed mixed on Friday, the final trading day of 2023, as the annual returns from UK equities were outshone by international markets.

Read more
20 Dec 2023 13:29

GSK buys rights to Hansoh Pharma antibody-drug conjugate

(Sharecast News) - GSK has agreed to buy the rights to an antibody-drug conjugate (ADC) - HS-20093 - from Chinese biopharmaceutical group Hansoh Pharma.

Read more
19 Dec 2023 15:36

German court quashes CureVac patent after challenge by BioNTech

CureVac shares drop 40%Dispute over intellectual property with BioNTech to continue

*

Read more
18 Dec 2023 17:21

Energy stocks lift UK's FTSE 100, Vodafone shines

Vodafone jumps as Iliad offers to merge Italian units

*

Read more
18 Dec 2023 10:07

GSK's dostarlimab trial in endometrial cancer meets primary endpoint

(Alliance News) - GSK PLC on Monday said a trial of dostarlimab in combination with niraparib for treating endometrial cancer has met its primary endpoint.

Read more
18 Dec 2023 07:55

LONDON BRIEFING: Games Workshop seals Amazon deal for Warhammer 40,000

(Alliance News) - Stocks in London were set to retreat slightly on Monday, in line with equity markets in Asia, at the start of the last week before the Christmas holidays.

Read more
18 Dec 2023 07:18

GSK sees success in Jemperli endometrial cancer trial

(Sharecast News) - GSK released positive headline results from the planned analysis of its trial of Jemperli in endometrial cancer on Monday.

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.